Skip to main content
logo
Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS · Delayed Price · Currency is USD
0.000001
-0.011099 (-99.99%)
At close: Sep 18, 2026

Virpax Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-12.07-15.19-21.65-12.06-4.34
Stock-Based Compensation
0.130.540.750.971.48
Other Operating Activities
----0.060.15
Change in Accounts Payable
0.780.6-0.99-0.691.34
Change in Other Net Operating Assets
-5.564.194.05-2.71-0.01
Operating Cash Flow
-16.71-9.85-17.85-14.54-1.38
Operating Cash Flow Growth
-----

Financing Activities

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Long-Term Debt Issued
---0.10.07
Long-Term Debt Repaid
----1.6-
Net Debt Issued (Repaid)
----1.50.07
Issuance of Common Stock
9.08--58.021.38
Other Financing Activities
----5.19-0.05
Financing Cash Flow
9.08--51.331.4

Net Cash Flow

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Cash Flow
-7.63-9.85-17.8536.790.01

Free Cash Flow

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Levered Free Cash Flow
-12.26-5.25-7.66-10.340.35
Unlevered Free Cash Flow
-12.2-5.25-7.66-10.280.44

Additional Metrics

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash Interest Paid
---0.36-
Change in Working Capital
-4.784.793.06-3.41.33